Rapid Triadic Communication Intention Elicitation Intervention to Improve Supportive Oncology Care Delivery for Patients with Advanced or Metastatic Refractory or Relapsed Gynecologic Cancer and Their Caregivers
This clinical trial tests the feasibility and how well the rapid triadic communication intention elicitation intervention works to improve supportive oncology care delivery for patients with gynecologic cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or that has spread from where it first started (primary site) to other places in the body (metastatic) and that has not responded to previous treatment (refractory) or that has come back after a period of improvement (relapsed) and their caregivers. Patients and caregivers nearly universally report that their supportive care needs are unaddressed by oncology providers. When unaddressed, patients and caregivers experience adverse outcomes, including decreased quality of care, a lack of a shared understanding of treatment goals, increased distress and anxiety, decisional conflict, and increased healthcare utilization. Using the rapid triadic communication intention elicitation intervention may improve communication and therefore care of patients with advanced or metastatic refractory or relapsed gynecologic cancer and their caregivers.